Skip to content
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Eyestem Research, India’s premier cell therapy company, announces successful completion of pre-IND meeting with FDA
Home
update
Eyestem Research, India’s premier cell therapy company, announces successful completion of pre-IND meeting with FDA
Post Author:
eyetem@admin
Leave a Reply
Cancel reply
Your email address will not be published.
Comment
Name
Email
Website
Post navigation
Previous Post
Eyestem, India’s pioneering cell therapy company, secures global funding
Next Post
Eyestem Research announces immediate availability of its Anti-Covid Screening (ACS) platform using iPSC derived lung progenitors
